Cell and context-dependent sorting of neuropathy-associated protein NDRG1 - insights from canine tissues and primary Schwann cell cultures.
Animals
Antibodies
Cell Cycle Proteins
/ genetics
Cells, Cultured
Dog Diseases
/ metabolism
Dogs
Gene Expression Regulation
Intracellular Signaling Peptides and Proteins
/ genetics
Male
Mesenchymal Stem Cells
Mutation
Polyneuropathies
/ genetics
Protein Isoforms
Schwann Cells
/ metabolism
Spermatids
Alaskan malamute
Charcot-Marie-tooth disease (CMT)
Dog
Greyhound
Microtubule-associated protein (MAP)
Microtubules
Myelin
Polyneuropathy
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
27 Apr 2019
27 Apr 2019
Historique:
received:
12
10
2018
accepted:
16
04
2019
entrez:
29
4
2019
pubmed:
29
4
2019
medline:
14
5
2019
Statut:
epublish
Résumé
Mutations in the N-myc downstream-regulated gene 1 (NDRG1) can cause degenerative polyneuropathy in humans, dogs, and rodents. In humans, this motor and sensory neuropathy is known as Charcot-Marie-Tooth disease type 4D, and it is assumed that analogous canine diseases can be used as models for this disease. NDRG1 is also regarded as a metastasis-suppressor in several malignancies. The tissue distribution of NDRG1 has been described in humans and rodents, but this has not been studied in the dog. By immunolabeling and Western blotting, we present a detailed mapping of NDRG1 in dog tissues and primary canine Schwann cell cultures, with particular emphasis on peripheral nerves. High levels of phosphorylated NDRG1 appear in distinct subcellular localizations of the Schwann cells, suggesting signaling-driven rerouting of the protein. In a nerve from an Alaskan malamute homozygous for the disease-causing Gly98Val mutation in NDRG1, this signal was absent. Furthermore, NDRG1 is present in canine epithelial cells, predominantly in the cytosolic compartment, often with basolateral localization. Constitutive expression also occurs in mesenchymal cells, including developing spermatids that are transiently positive for NDRG1. In some cells, NDRG1 localize to centrosomes. Overall, canine NDRG1 shows a cell and context-dependent localization. Our data from peripheral nerves and primary Schwann cell cultures suggest that the subcellular localization of NDRG1 in Schwann cells is dynamically influenced by signaling events leading to reversible phosphorylation of the protein. We propose that disease-causing mutations in NDRG1 can disrupt signaling in myelinating Schwann cells, causing disturbance in myelin homeostasis and axonal-glial cross talk, thereby precipitating polyneuropathy.
Sections du résumé
BACKGROUND
BACKGROUND
Mutations in the N-myc downstream-regulated gene 1 (NDRG1) can cause degenerative polyneuropathy in humans, dogs, and rodents. In humans, this motor and sensory neuropathy is known as Charcot-Marie-Tooth disease type 4D, and it is assumed that analogous canine diseases can be used as models for this disease. NDRG1 is also regarded as a metastasis-suppressor in several malignancies. The tissue distribution of NDRG1 has been described in humans and rodents, but this has not been studied in the dog.
RESULTS
RESULTS
By immunolabeling and Western blotting, we present a detailed mapping of NDRG1 in dog tissues and primary canine Schwann cell cultures, with particular emphasis on peripheral nerves. High levels of phosphorylated NDRG1 appear in distinct subcellular localizations of the Schwann cells, suggesting signaling-driven rerouting of the protein. In a nerve from an Alaskan malamute homozygous for the disease-causing Gly98Val mutation in NDRG1, this signal was absent. Furthermore, NDRG1 is present in canine epithelial cells, predominantly in the cytosolic compartment, often with basolateral localization. Constitutive expression also occurs in mesenchymal cells, including developing spermatids that are transiently positive for NDRG1. In some cells, NDRG1 localize to centrosomes.
CONCLUSIONS
CONCLUSIONS
Overall, canine NDRG1 shows a cell and context-dependent localization. Our data from peripheral nerves and primary Schwann cell cultures suggest that the subcellular localization of NDRG1 in Schwann cells is dynamically influenced by signaling events leading to reversible phosphorylation of the protein. We propose that disease-causing mutations in NDRG1 can disrupt signaling in myelinating Schwann cells, causing disturbance in myelin homeostasis and axonal-glial cross talk, thereby precipitating polyneuropathy.
Identifiants
pubmed: 31029158
doi: 10.1186/s12917-019-1872-2
pii: 10.1186/s12917-019-1872-2
pmc: PMC6487035
doi:
Substances chimiques
Antibodies
0
Cell Cycle Proteins
0
Intracellular Signaling Peptides and Proteins
0
N-myc downstream-regulated gene 1 protein
0
Protein Isoforms
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121Subventions
Organisme : Agria Djurförsäkring
ID : N2015-0016
Organisme : Svenska Kennelklubben
ID : N2015-0016
Références
Hum Reprod. 2000 Feb;15(2):256-63
pubmed: 10655294
Am J Hum Genet. 2000 Jul;67(1):47-58
pubmed: 10831399
Histochem Cell Biol. 2002 Nov;118(5):399-408
pubmed: 12432451
Cancer Res. 2003 Apr 15;63(8):1731-6
pubmed: 12702552
Oncogene. 2004 Jul 22;23(33):5675-81
pubmed: 15184886
J Biol Chem. 2004 Sep 10;279(37):38597-602
pubmed: 15247272
Glia. 2004 Sep;47(4):325-34
pubmed: 15293230
Neurobiol Dis. 2004 Nov;17(2):290-9
pubmed: 15474366
Cancer Res. 2004 Nov 1;64(21):7655-60
pubmed: 15520163
Neuromuscul Disord. 2007 Feb;17(2):163-8
pubmed: 17142040
PLoS One. 2007 Sep 05;2(9):e844
pubmed: 17786215
Cell Motil Cytoskeleton. 2009 Oct;66(10):893-908
pubmed: 19479825
PLoS One. 2010 Jun 22;5(6):e11258
pubmed: 20582309
FASEB J. 2010 Nov;24(11):4153-66
pubmed: 20667976
Neurobiol Dis. 2011 Jun;42(3):368-80
pubmed: 21303696
Biochem Biophys Res Commun. 2011 Jul 29;411(2):227-34
pubmed: 21708134
J Neurosci. 2011 Nov 9;31(45):16369-86
pubmed: 22072688
PLoS One. 2013;8(2):e54547
pubmed: 23393557
Biosci Rep. 2013 Jun 11;33(3):null
pubmed: 23634903
Carcinogenesis. 2013 Sep;34(9):1943-54
pubmed: 23671130
J Cell Sci. 2013 Sep 1;126(Pt 17):3961-71
pubmed: 23813961
PLoS One. 2013 Jul 09;8(7):e68206
pubmed: 23874544
PLoS One. 2013 Sep 16;8(9):e75473
pubmed: 24066183
PLoS One. 2014 Jan 31;9(1):e87268
pubmed: 24498060
J Cell Biol. 2014 Mar 31;204(7):1219-36
pubmed: 24687281
Biochem Biophys Res Commun. 2015 Mar 27;459(1):161-5
pubmed: 25712528
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11583-8
pubmed: 26324937
Database (Oxford). 2015 Nov 13;2015:null
pubmed: 26568329
Sci Rep. 2016 Aug 23;6:31781
pubmed: 27549422
Oncogene. 2017 Jul 27;36(30):4323-4335
pubmed: 28346422
Mol Oncol. 2017 Jun;11(6):655-669
pubmed: 28371345
Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2644-2663
pubmed: 29679718
J Biol Chem. 1996 Nov 22;271(47):29659-65
pubmed: 8939898
Lab Invest. 1997 Jul;77(1):85-92
pubmed: 9251681